Table 2.

Comparison of blood biochemistry indices between different treatments in COVID-19 convalescents

Indices	Reference range	Non-treatment(n = 425)	TCM treatment(n = 143)	P value
Liver function
GLB (g/L)	20-40	26.81±4.66	26.61±3.83	0.6427
A/G	1.5-2.5	1.75±0.31	1.79±0.30	0.1587
AST/ALT	0.5-1.5	1.42±0.64	1.36±0.63	0.3558
GGT (U/L)	7-60	35.10±33.06	27.31±18.13**↓	0.0088
ALT (U/L)	7-50	20.70±19.87	20.55±16.36	0.9398
TBA (µmol/L)	0-10	7.09±6.74	7.82±4.54	0.2386
PA (g/L)	0.2-0.4	0.29±0.06	0.35±0.62*↑	0.0492
ALB (g/L)	35-52	45.68±4.11	46.66±2.85**↑	0.0098
TP (g/L)	65-85	72.50±4.71	73.27±3.89	0.0818
Kidney function
CysC (mg/L)	0-1.5	0.96±0.22	0.96±0.15	0.8490
UA (µmol/L)	119-416.5	315.30±78.2	316.80±76.43	0.8452
Urea (mmol/L)	2.78-8.07	4.39±1.40	4.35±1.05	0.7672
Cr (µmol/L)	45-104	58.49±17.54	58.60±16.30	0.9451
CO2CP (mmol/L)	21-31	24.54±2.79	24.79±2.38	0.3435
β2-MG (mg/L)	0.8-2.2	1.768±0.68	1.69±0.47	0.2247
Blood lipid level
ApoAⅠ/ApoB	0.8-2.2	1.80±0.58	1.70±0.54	0.0799
LP(a) (mg/dL)	0-30	20.76±22.76	19.02±21.99	0.4322
ApoB (g/L)	0.60-1.33	0.85±0.23	0.93±0.26***↑	0.0009
ApoAⅠ (g/L)	1.04-2.25	1.44±0.28	1.46±0.23	0.4438
TC (mmol/L)	0-5.2	4.98±1.15	5.18±1.18	0.0749
TG (mmol/L)	0-2.6	2.42±2.02	2.59±1.47	0.3644
HDL-C (mmol/L)	1-1.55	1.20±0.35	1.17±0.29	0.3449
LDL-C (mmol/L)	1.90-3.10	2.91±0.93	3.13±1.05 *↑	0.0194
Myocardial enzyme spectrums
α-HBDH (U/L)	78-182	125.46±25.51	124.07±26.12	0.5842
LDH (U/L)	135-214	174.70±37.35	166.32±32.89*↓	0.0195
CK-MB (U/L)	0-25	6.14±4.00	5.83±3.41	0.4233
CK (U/L)	20-200	26.26±39.13	20.18±13.97	0.0764
AST (U/L)	15-40	22.45±12.93	22.14±9.74	0.7984

Continuous variables were analyzed using one-way ANOVA (Tamhane's T2) test. *P<0.05, **P<0.01, ***P<0.001 vs non-treatment group. The symbols ↓ and ↑ represented significantly higher or lower.